NASDAQ:XXII - Nasdaq - US90137F4000 - Common Stock - Currency: USD
Overall XXII gets a fundamental rating of 3 out of 10. We evaluated XXII against 8 industry peers in the Tobacco industry. XXII scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. XXII has a decent growth rate and is not valued too expensively.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -95.38% | ||
ROE | -564.61% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | -26.86 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.68 | ||
Quick Ratio | 0.52 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 0.5 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
0.75
-0.02 (-3.2%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 0.5 | ||
P/S | 0.2 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 1.32 | ||
P/tB | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -95.38% | ||
ROE | -564.61% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 22.16% | ||
Cap/Sales | 0.89% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 0.68 | ||
Quick Ratio | 0.52 | ||
Altman-Z | -26.86 |